Ocular Therapeutix (OCUL) Tops Q1 EPS by 4c; Sees DEXTENZA NDA Submission in H215

Go back to Ocular Therapeutix (OCUL) Tops Q1 EPS by 4c; Sees DEXTENZA NDA Submission in H215
(NASDAQ: OCUL) Delayed: 10.19 +0.32 (3.24%)
Previous Close $9.87    52 Week High $14.50 
Open $10.11    52 Week Low $4.04 
Day High $10.55    P/E N/A 
Day Low $10.06    EPS $0.00 
Volume 977,410